Project Grant K01DA065031
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Southern California a Project Grant totaling $149,766 on August 12, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate simultaneous nicotine, alcohol, and cannabis co-use among young adults through May 15, 2029. This research deliverable addresses a significant gap in the existing literature by comprehensively examining patterns of multi-substance use...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a Project Grant of $1.014 million under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through May 31, 2030. This award supports translational and preclinical research investigating the epigenetic mechanisms underlying cannabis use disorder (CUD) through a novel volitional tetrahydrocannabinol (THC) consumption model in...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $542,187 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to the Public Health Institute on June 15, 2026, for "Assessing the Role of Cannabis in Sober Living Houses," with completion targeted for March 31, 2031. This research initiative will generate empirical evidence and assessment tools addressing a critical gap in understanding cannabis use among individuals in recovery...
- Federal Grant Award Summary Cambridge Health Alliance received a $776,604 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 15, 2026, with completion targeted for March 31, 2031. The grant funds a mixed-methods research study examining the causal impact of recreational cannabis legalization on cannabis, nicotine, and alcohol (CNA) use prevalence, intensity, risk perception, and disorder diagnosis among...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $708,190 Project Grant effective July 1, 2026 through May 31, 2031 under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant funds a controlled clinical research initiative examining the pharmacokinetic and pharmacodynamic effects of varying tetrahydrocannabinol (THC) to cannabidiol (CBD) ratios in cannabis edibles. The research comprises two double-blind,...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a Project Grant totaling $686,692 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct prospective research on cannabis use reduction and its impact on patient functioning. Initiated on September 1, 2025, and extending through July 31, 2030, this eight-week clinical trial will enroll 176 adults aged 18 and older with Cannabis Use Disorder...
- Federal Grant Award Summary Oregon Health & Science University received a $905,044 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective May 1, 2026 through April 30, 2028. This mixed-methods research study will examine current practices and barriers related to electronic nicotine delivery systems (ENDS) use assessment and cessation assistance in primary care settings across 22 clinics serving over 154,000...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $734,188 Project Grant to the University of California, San Diego, effective July 15, 2026, through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative investigates sex differences in cannabis withdrawal mechanisms and recovery of neuropsychological and behavioral functioning in emerging adults (ages 18-25) with heavy cannabis use. The project will recruit...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Project Grant Award Summary Dartmouth College received a $450,313 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, through May 31, 2027. The award funds research investigating the impact of psychotherapeutic advertising claims (PAC) and mental health warning labels on cannabis purchasing behaviors among light-to-moderate cannabis users experiencing depression and/or anxiety symptoms....
The National Institute on Drug Abuse (NIDA) awarded the Research Foundation For Mental Hygiene, Inc. (operating through the New York State Psychiatric Institute) a Project Grant totaling $195,804 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period August 1, 2026 through July 31, 2031. This research project investigates the effects of cannabis on nicotine use patterns, specifically examining how cannabis influences electronic nicotine delivery system (ENDS) use in young and emerging adults aged 18-35 who use both substances. The award supports a novel integrated research methodology combining human laboratory studies with ecological momentary assessment (EMA) procedures to examine direct and naturalistic associations between cannabis and ENDS use. The project deliverables include controlled laboratory testing using a double-blind, placebo-controlled design with 78 participants (39 males, 39 females) to assess how vaporized cannabis administration at varying doses (0mg, 15mg, and 35mg delta-9-tetrahydrocannabinol) directly impacts ENDS use behavior, supplemented by 14-day EMA data collection to examine cannabis as a proximal risk factor for naturalistic ENDS use in daily life. The research specifically addresses sex-based differences in substance co-use patterns and seeks to establish associations between controlled laboratory observations and real-world behavior, addressing a documented gap in understanding of nicotine-cannabis co-use mechanisms and health outcomes related to tobacco use disorder and cannabis use disorder.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $195.8k | 7/17/26 |